114 related articles for article (PubMed ID: 27488745)
1. Structure activity relationship study on the peptide hormone preptin, a novel bone-anabolic agent for the treatment of osteoporosis.
Amso Z; Kowalczyk R; Watson M; Park YE; Callon KE; Musson DS; Cornish J; Brimble MA
Org Biomol Chem; 2016 Oct; 14(39):9225-9238. PubMed ID: 27488745
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of truncated analogues of preptin-(1–16), and investigation of their ability to stimulate osteoblast proliferation.
Kowalczyk R; Yang SH; Brimble MA; Callon KE; Watson M; Park YE; Cornish J
Bioorg Med Chem; 2014 Jul; 22(14):3565-72. PubMed ID: 24932835
[TBL] [Abstract][Full Text] [Related]
3. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo.
Cornish J; Callon KE; Bava U; Watson M; Xu X; Lin JM; Chan VA; Grey AB; Naot D; Buchanan CM; Cooper GJ; Reid IR
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E117-22. PubMed ID: 16912056
[TBL] [Abstract][Full Text] [Related]
4. Preptin analogues: chemical synthesis, secondary structure and biological studies.
Buchanan CM; Peng Z; Cefre A; Sarojini V
Chem Biol Drug Des; 2013 Oct; 82(4):429-37. PubMed ID: 23745966
[TBL] [Abstract][Full Text] [Related]
5. Effects and differentiation activity of IGF-I, IGF-II, insulin and preptin on human primary bone cells.
Bosetti M; Sabbatini M; Nicolì E; Fusaro L; Cannas M
Growth Factors; 2013 Apr; 31(2):57-65. PubMed ID: 23410103
[TBL] [Abstract][Full Text] [Related]
6. Functional stapled fragments of human preptin of minimised length.
Lubos M; Mrázková L; Gwozdiaková P; Pícha J; Buděšínský M; Jiráček J; Kaminský J; Žáková L
Org Biomol Chem; 2022 Mar; 20(12):2446-2454. PubMed ID: 35253830
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts.
Liu YS; Lu Y; Liu W; Xie H; Luo XH; Wu XP; Yuan LQ; Liao EY
Amino Acids; 2010 Mar; 38(3):763-9. PubMed ID: 19333718
[TBL] [Abstract][Full Text] [Related]
8. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
Sharan K; Mishra JS; Swarnkar G; Siddiqui JA; Khan K; Kumari R; Rawat P; Maurya R; Sanyal S; Chattopadhyay N
J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
[TBL] [Abstract][Full Text] [Related]
9. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
10. Amylin(1-8) is devoid of anabolic activity in bone.
Ellegaard M; Thorkildsen C; Petersen S; Petersen JS; Jørgensen NR; Just R; Schwarz P; Ramirez MT; Stahlhut M
Calcif Tissue Int; 2010 Mar; 86(3):249-60. PubMed ID: 20127324
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
[TBL] [Abstract][Full Text] [Related]
12. Characterization of preptin-induced insulin secretion in pancreatic β-cells.
Cheng KC; Li YX; Asakawa A; Ushikai M; Kato I; Sato Y; Cheng JT; Inui A
J Endocrinol; 2012 Oct; 215(1):43-9. PubMed ID: 22787110
[TBL] [Abstract][Full Text] [Related]
13. How to blast osteoblasts? Novel dicarba analogues of amylin-(1-8) to treat osteoporosis.
Kowalczyk R; Brimble MA; Callon KE; Watson M; Cornish J
Bioorg Med Chem; 2012 Oct; 20(20):6011-8. PubMed ID: 22998786
[TBL] [Abstract][Full Text] [Related]
14. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.
Koh AJ; Demiralp B; Neiva KG; Hooten J; Nohutcu RM; Shim H; Datta NS; Taichman RS; McCauley LK
Endocrinology; 2005 Nov; 146(11):4584-96. PubMed ID: 16081645
[TBL] [Abstract][Full Text] [Related]
15. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro bone cell activity of analogues of the cyclohexapeptide dianthin G.
Amso Z; Kowalczyk R; Park YE; Watson M; Lin JM; Musson DS; Cornish J; Brimble MA
Org Biomol Chem; 2016 Jul; 14(26):6231-43. PubMed ID: 27264279
[TBL] [Abstract][Full Text] [Related]
17. Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults.
El-Eshmawy M; Abdel Aal I
Appl Physiol Nutr Metab; 2015 Mar; 40(3):218-22. PubMed ID: 25675353
[TBL] [Abstract][Full Text] [Related]
18. Discovery and structure-activity relationship of thienopyridine derivatives as bone anabolic agents.
Saito K; Nakao A; Shinozuka T; Shimada K; Matsui S; Oizumi K; Yano K; Ohata K; Nakai D; Nagai Y; Naito S
Bioorg Med Chem; 2013 Apr; 21(7):1628-42. PubMed ID: 23453217
[TBL] [Abstract][Full Text] [Related]
19. Preptin: A New Bone Metabolic Parameter?
Ungureanu MC; Bilha SC; Hogas M; Velicescu C; Leustean L; Teodoriu LC; Preda C
Metabolites; 2023 Sep; 13(9):. PubMed ID: 37755271
[TBL] [Abstract][Full Text] [Related]
20. Anabolic effects of intermittent PTH on osteoblasts.
Greenfield EM
Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
